Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Updates in Acne Management in Gender Diverse Patients
Description
The presentation discusses the unique challenges and considerations in managing acne for gender diverse patients, particularly those undergoing hormonal treatments. The speaker, experienced in providing care for transgender patients, emphasizes that skin disorders can worsen body image dissatisfaction and exacerbate issues like gender dysphoria, anxiety, and depression. With an increasing number of younger adults identifying as transgender, there is a growing need for healthcare providers to equip themselves to address these patients' dermatological needs effectively. The discussion highlights how hormonal treatments, such as testosterone and estrogen, impact acne, with a higher incidence observed in trans masculine patients receiving testosterone. The speaker argues against a "wait-and-see" approach to treating acne in these patients, noting that acute and severe cases are common and should not be neglected. Treatment options include topical medications, oral antibiotics, and isotretinoin, though the latter requires careful monitoring for potential mental health side effects. Insight into the impact of chest binding on acne and guidance on safe practices is also provided. The speaker concludes that effective acne management is crucial in this demographic due to the potential implications for mental health and future surgical plans, and thanks medical students who contributed to the research.
View moreConclusions
- Acne is more prevalent in transgender and gender diverse patients, especially those undergoing testosterone therapy.
- Acne in this population can worsen mental health, leading to increased depression and anxiety.
- Age at initiation of testosterone therapy is a predictive factor for acne severity, with younger patients exhibiting higher rates.
- Isotretinoin is effective and appears safe for treating severe acne in transgender patients on testosterone.
- Proper management strategies for acne in this population must consider the potential for depression and the need for mental health support.
- There is a risk of teratogenic effects with isotretinoin, requiring careful contraception discussions with patients capable of pregnancy.
- Chest binding is common among transmasculine individuals and can exacerbate skin issues, needing education on safe practices.
- Overall awareness of dermatological needs in transgender patients is crucial for providing comprehensive care.
- Brown A. About 5% of young adults in the U.S. say their gender is different from their sex assigned at birth. Pew Research Center, 2022.
- Herman JL, Flores AR, O'Neill K. How many adults identify as transgender in the United States? The Williams Institute. 2022.
- 1. Owen-Smith AA, Gerth J, Sineath RC, et al. Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals. J Sex Med 2018;15(4):591-600.
- 2. Gonzales G, Henning-Smith C. Barriers to Care Among Transgender and Gender Nonconforming Adults. The Milbank quarterly. 2017;95(4):726-748. [PubMed: 29226450]
- Giltay EJ, Gooren LJ. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab. 2000 Aug;85(8):2913-21.
- Braun H, Zhang Q, Getahun D, Silverberg MJ, Tangpricha V, Goodman M, Yeung H. Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone. JAMA Dermatol. 2021 Mar 1;157(3):344-346.
- Thoreson N, Park JA, Grasso C, et al. Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy. JAMA Dermatol. 2021;157(3):290-295. doi:10.1001/jamadermatol.2020.5347.
- Chu L, Gold S, Harris C, Lawley L, Gupta P, Tangpricha V, Goodman M, Yeung H. Incidence and Factors Associated With Acne in Transgender Adolescents on Testosterone: A Retrospective Cohort Study. Endocr Pract. 2023 May;29(5):353-355.
- Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014 Dec;124(6):1120-1127.
- Yeung H, Kahn B, Ly BC, Tangpricha V. Dermatologic Conditions in Transgender Populations. Endocrinology and Metabolism Clinics. 2019 Jun 1;48(2):429-40.
- Peitzmeier S, Gardner I, Weinand J, Corbet A, Acevedo K. Health impact of chest binding among transgender adults: a community-engaged, cross-sectional study. Culture, Health & Sexuality. 2017 Jan;19(1):64-75.